Moffitt Looking For Participants In New Lung Cancer Prevention Trial
Heavy smokers and those who quit may have a chance to lower their risk of getting lung cancer. Researchers at H. Lee Moffitt Cancer Center & Research Institute are testing a new drug that could reverse some of the smoking-related damage to their lungs. Moffitt investigators will determine whether Sulindac may reverse some of the lung abnormalities associated with smoking.
This entry was posted on Saturday, March 31st, 2007 at 3:05 pm and is filed under Research, Education, Smoking Cessation. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.